From: Rheumatic heart disease prevalence in Namibia: a retrospective review of surveillance registers
n | % | |
---|---|---|
Sex (n = 808) | ||
Women Men | 523 | 65 |
285 | 35 | |
Age at Registration (n = 802) | ||
0–9 years | 181 | 23 |
10–19 years | 250 | 31 |
20–29 years | 143 | 18 |
30–39 years | 115 | 14 |
40–49 years | 36 | 4.5 |
≥ 50 years | 77 | 10 |
Death over 11 years (n = 74) | ||
Women | 35 | 6.7 |
Men | 39 | 14 |
NYHA Classification* (n = 335) | ||
NYHA I | 254 | 76 |
NYHA II | 45 | 13 |
NYHA III | 2 | 6.9 |
NYHA IV | 13 | 3.9 |
Valve Affected (n = 467) | ||
Aortic Valve Disease | 59 | 13 |
Mitral Valve Disease | 269 | 58 |
Tricuspid Valve Disease | 23 | 4.9 |
Mixed Valve Disease | 90 | 19 |
Unclassified Valve Disease | 26 | 5.6 |
Treatment & Surgery (n = 791) | ||
Warfarin | 164 | 21 |
Penicillin prophylaxis | 339 | 43 |
Surgery | 288 | 36 |
Co-morbidities & Complications | ||
Acute Rheumatic Fever/Rheumatic Fever | 19 | 2.3 |
Atrial Fibrillation | 35 | 4.3 |
Congenital Heart Disease | 5 | 0.6 |
Hypertension | 22 | 2.7 |
Stroke | 14 | 1.7 |
Others | 15 | 1.8 |